Mersana Therapeutics Financial Overview
Mersana Therapeutics's market cap is currently $145.46M. The company's EPS TTM is $-1.51; its P/E ratio is -2.07; Mersana Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-3.05. See an overview of income statement, balance sheet, and cash flow financials.
